PREVIEW: Goldman Sachs Q2 EPS, revenue expected to rise
** Goldman Sachs GS.N shares down 1.5% to $702.54 ahead of Q2 earnings due before the opening bell on Wednesday
** The bank is expected to post EPS of $9.53 on revenue of around $13.46 bln, per LSEG data, vs yr-ago results of $8.62 per share and $12.73 bln in revenue
** GS has met or topped revenue expectations for eight straight quarters and seven of past eight on EPS side, with most recent miss in Q2 2023
** The S&P 500 bank index .SPXBK slumped 1.6% on Tuesday, after a flurry of banks including JP Morgan JPM.N and Wells Fargo .WFC.N kicked off earnings season
** GS shares up ~23% YTD stock performance vs ~4% climb in Dow Industrials .DJI
** GS options imply a 3.3% swing for the shares, in either direction, by Friday, according to options analytics service Trade Alert; on average, the stock has moved 2.1% on the day of results over the last 8 qtrs
Related Articles
Bitcoin Price Forecast: Trends and Investment Outlook from 2025 to 2030
From $0.01 in 2009 to $120,000+ in 2025, Bitcoin has evolved from obscurity to a globally recognized financial asset. While institutions and governments increasingly embrace it, investors must remain vigilant against volatility, security risks, and scams.
What is the Future of Stablecoins? Here are Some Stablecoin Stocks to Watch
With regulations solidifying, institutional money flowing in, and global market expansion accelerating, stablecoin-related stocks could experience unprecedented growth.
What Is the GENIUS Act, and Why Is Its Impact Comparable to a Bitcoin Spot ETF?
The GENIUS Act represents a groundbreaking federal regulatory framework for U.S. stablecoins, defining legal issuance standards, oversight responsibilities, consumer protections, and reserve requirements. While its primary objective is to advance U.S. financial interests, it will significantly sha
[IN-DEPTH ANALYSIS] UnitedHealth (UNH): Can the Healthcare Giant Recover After Its Epic Collapse?
Once a Wall Street sweetheart, UnitedHealth Group (UNH) dominated the US healthcare industry with its unbeatable vertical empire, spanning insurance, clinics, pharmacies, and data analytics..jpg)
Wells Fargo Q1 2025: Is it a Fragile Fortress or a Mispriced Revival
TradingKey - Wells Fargo's (WFC) Q1 2025 results present a paradox: resiliency without momentum. Net income on the surface was up 6% year-over-year at $4.9 billion, which is $1.39 a diluted share for a 16% EPS lift driven by forceful share repurchases.
